Table 1.
Characteristic | Group 1 (GOS 1/2) | Group 2 (GOS 3–5) | p |
n | 34 | 9 | - |
Age, mean ± SD (years) | 63.9 ± 14 | 64.7 ± 11 | 0.892 |
Male sex, n (percentage) | 14 (41) | 6 (66) | 0.263 |
Initial rhythm | |||
VF/VT, n (percentage) | 4 (12) | 4 (44) | 0.046 |
PEA/asystole, n (percentage) | 30 (88) | 5 (55) | |
Low-flow time, median [range], (minutes) | 11.5 [5–90] | 13 [3–35] | 0.952 |
GCS score, mean ± SD | 6.1 ± 3 | 12.1 ± 3 | < 0.001 |
Pupillary reaction to light, n (percentage) | 20 (59) | 9 (100) | 0.020 |
Sedation use, n (percentage) | 10 (29) | 1 (11) | 0.407 |
Δt from NSE sampling, mean ± SD (hours) | 20.2 ± 8.3 | 28.4 ± 8.7 | 0.013 |
GOS, Glasgow outcome scale; VF, ventricular fibrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity; GCS, Glasgow Coma Scale; Δt, time elapsed from cardiopulmonary resuscitation until blood sampling for NSE measurement; NSE, neuron-specific enolase.